Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

$HIMSPress releaseOct 6, 2026, 9:52 PM ETRead the release

Kahn Swick & Foti issued a solicitation reminding HIMS investors with losses they have until November 2, 2026 to file lead plaintiff applications in the securities class action Velanki v. Hims & Hers Health, Inc. The class action alleges HIMS failed to disclose material information between August 4, 2025 and July 29, 2026, following an FTC lawsuit accusing the telehealth company of sharing sensitive health data with advertisers and deceptive billing practices.

Key figures

Class period
August 4, 2025 to July 29, 2026
Stock decline
14.73%
Lead plaintiff deadline
November 2, 2026

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.